Donna R. Cryer, JD, has channeled her personal experience as an inflammatory bowel disease and liver transplant patient into professional advocacy. She is the president and chief executive officer of the Global Liver Institute. Ms. Cryer serves on the executive committee of the People-Centered Research Foundation, the boards of directors of the Society for Participatory Medicine and the Personalized Medicine Coalition, and as a patient representative to the U.S. Food and Drug Administration and the American Board of Internal Medicine’s Gastroenterology Specialty Board. Previously, Ms. Cryer served as the patient and consumer representative on the U.S. Government Accountability Office’s Health Information Technology Policy Committee, the federal advisory body to the National Coordinator for Health Information Technology, and as a merit reviewer for the Patient-Centered Outcomes Research Institute. She was also a member of the Stakeholder Advisory Group for the NIH Health Care Systems Research Collaboratory and a guidelines committee of the American Society of Clinical Oncology. Ms. Cryer has been named one of the Top Blacks in Healthcare by the Milken Institute School of Public Health at George Washington University and BlackDoctors.org, one of the Top 10 Patients Who Make an Impact by Health 2.0, and one of PharmaVoice’s 100 Most Inspiring People. She received a Juris Doctorate from the Georgetown University Law Center.